IL10 and melanoma: To check the efficacy of NLGP in regulating the number of IL-10-secreting MSCs in vivo, two groups of mice with established B16 melanoma tumor on around the 7th day of inoculation were either administered with NLGP (25 μg/mice) or PBS weekly for 4 weeks in total.